Search results
Results from the WOW.Com Content Network
DIC may cause a range of symptoms, including abnormal bleeding, breathlessness, chest pain, neurological symptoms, low blood pressure, or swelling. [28] COVID‑19 vaccines have some adverse effects that are listed as common in the two or three days following vaccination which are usually mild and temporary. [21]
SIRVA is caused by improper insertion of the needle used in injections. It is "a preventable occurrence caused by the injection of a vaccine into the shoulder capsule rather than the deltoid muscle. As a result, inflammation of the shoulder structures causes patients to experience pain, a decreased range of motion, and a decreased quality of life."
CIPN afflicts between 30% and 40% of patients undergoing chemotherapy. Antineoplastic agents in chemotherapy are designed to eliminate rapidly dividing cancer cells, but they can also damage healthy structures, including the peripheral nervous system. [1] CIPN involves various symptoms such as tingling, pain, and numbness in the hands and feet. [2]
UCLA School of Nursing Assistant Professor Kristen Choi joins Yahoo Finance Live to discuss her experience as a participant in the Pfizer COVID-19 vaccine trial.
Other neurological symptoms appear to be rare, but may affect half of patients who are hospitalized with severe COVID-19. Some reported symptoms include delirium , stroke , brain hemorrhage , memory loss , psychosis , peripheral nerve damage, anxiety , and post-traumatic stress disorder . [ 62 ]
For the study, researchers followed 113 patients with COVID-19 and 39 healthy patients as controls. After six months, 40 of the COVID-19 patients developed symptoms of long COVID.
Hypoesthesia is one of the negative sensory symptoms associated with cutaneous sensory disorder (CSD). In this condition, patients have abnormal disagreeable skin sensations that can be due to increased nervous system activity (stinging, itching or burning) or decreased nervous system activity (numbness or hypoesthesia). [6]
A lot of POTS patients, whether they develop it due to COVID or not, are predominantly young women in their 20s and 30s, and many of them have Ehlers-Danlos syndrome, says Dr. Chung.